Adenomatous polyposis coli (APC) is a multifunctional tumour suppressor protein, central to development and the mature organism. It is mutated in most cases of colorectal cancer, rendering it ineffective in mediating b-catenin degradation. We show that localization of full-length APC in colon carcinoma and noncancer cell lines is independent of cell density. However, the location of truncated APC is a function of cell density and in high-density cells truncated APC is predominantly not nuclear. Although the distribution of truncated APC and b-catenin is closely linked in subconfluent SW480 cells, at high cell density they are not colocalized. We postulated that in this cell line this could be due to an increase in b-catenin bound to E-cadherin with formation of adherens junctions at high cell density. However, while in coimmunoprecipitation assays we observe an increase in binding between bcatenin and E-cadherin and a corresponding decrease in binding between b-catenin and APC at high cell density, we did not observe a strict colocalization of b-catenin and E-cadherin at the membrane of all cells.
Introduction
The tumour suppressor protein adenomatous polyposis coli (APC) is mutated in the inherited condition, familial APC, predisposing the affected individual to colorectal cancer Joslyn et al., 1991; Kinzler et al., 1991; Nishisho et al., 1991) . Mutations in APC are also identified as early mutation events in most sporadic cases of colorectal cancer (Fearon and Vogelstein, 1990; Powel et al., 1992) . Many colorectal cancers that do not have mutations in APC have activating mutations in bcatenin, a key component of the wnt signaling pathway (Bienz, 2002) . One of the most widely studied effects of APC mutation is on b-catenin. Mutation of APC leads to elevated levels of nuclear b-catenin that transactivates members of the TCF/LEF family (Behrens et al., 1996) and results in inappropriate expression of target genes such as c-myc, cyclin D1 and matrilysin (He et al., 1998; Crawford et al., 1999; Roose et al., 1999; Shtutman et al., 1999; Tetsu and McCormick, 1999) . Alternatively, activation of this pathway can occur through mutations in b-catenin that render it protected from ubiquitinproteasomal degradation (Aberle et al., 1997) .
Several studies show that APC has a CRM1-dependent nuclear export function for b-catenin that regulates subcellular localization and turnover (Henderson 2000; Neufeld et al., 2000; Rosin-Arbesfeld et al., 2000) . CRM1 is a nuclear export receptor for leucine rich export sequences such as those found in APC (Fornerod et al., 1997; Gorlich, 1998) . More recently it has been shown that the rate of nuclear export of APC determines the transcriptional activity of b-catenin (Rosin-Arbesfeld et al., 2003) . This likely occurs through a nuclear export sequence (NES) that resides in the central domain of APC. The NES in the Nterminal region of APC have also been shown to be involved in exporting b-catenin from the nucleus, although it is unclear which sequences are dominant over the others. In addition to redistribution of bcatenin via APC, a CRM1-independent nuclear export mechanism for b-catenin has also been reported (Eleftheriou et al., 2001; Wieschens and Fagotto, 2001) . One proposal to explain this suggests that the rate of CRM1-independent exit is relatively slow and this may be accelerated by APC-mediated export (Rosin-Arbesfeld et al., 2003) .
Knowledge of endogenous APC localization within a cell, under defined cellular conditions is fundamental to understanding its function, and how this might alter with disease. The close association of localization between APC and b-catenin has been documented in the cell line SW480 that has truncated APC (Henderson, 2000; Rosin-Arbesfeld et al., 2000 , 2003 and is suggested to be linked to its function in exporting bcatenin from the nucleus. There have been reports to show that APC and b-catenin undergo a cell densitydependent redistribution, that might therefore reflect alteration in function (Brabletz et al., 2001; Brocardo et al., 2001; Zhang et al., 2001; Dietrich et al., 2002) . None of the studies to date carries out a comparison of changes in localization of APC and b-catenin with cell density.
We define and compare the subcellular distribution of endogenous full-length APC with endogenous truncated APC in colon carcinoma and noncancer epithelial cell lines. Since there is a functional link between APC and b-catenin, locations of APC species were correlated with b-catenin distributions. Comparisons were carried out at different stages of cell growth, that is cells grown to low or high cell density, representing cells that may be found at the invasive front and the central mass of tumours, respectively (Brabletz et al., 2001) . Specifically, we focus entirely on endogenous protein to maintain the balance of interacting or controlling components, believing that ectopic expression may affect this. We studied two colon carcinoma cell lines, HCT116, that has wild-type APC, but mutated b-catenin and SW480 that has a mutation in APC at 1338 amino acids resulting in truncation of the protein at this point (while loss of heterozygosity results in complete removal of the second allele). HEK293 (human embryonic kidney) cells and C57MG (mouse mammary epithelial) cells were used as a further system to study full-length APC and wild-type bcatenin. We demonstrate that while full-length APC location does not vary with cell density, truncated APC shows a cell density-dependent redistribution. Furthermore redistribution of truncated APC such that it is no longer predominantly nuclear is coincident with uncoupling of APC/b-catenin colocalization. To explain this relocalization in the cancer cell line SW480, we tested the possibility that the formation of adherens junctions at high cell density might affect mobility and localization of b-catenin, favouring interactions between Ecadherin and b-catenin over APC and b-catenin. We show that there are increased interactions detected between b-catenin and E-cadherin from low to high cell density and a corresponding decrease in interactions detected between b-catenin and APC. However, although we demonstrate a global alteration in protein interactions, the formation of junctions cannot entirely explain the density-dependent redistribution of APC and b-catenin.
Results

Localization of full-length APC and b-catenin does not vary with cell density
The antibody M-APC was used in these studies and is directed to the central region of APC (Nathke et al., 1996) . In subconfluent HCT116 cells either cytoplasmic staining or equi-cytoplasmic/nuclear staining of fulllength APC is observed (Figure 1b) . b-catenin is predominantly located around the membrane with faint cytoplasmic staining consistent with previous reports (Figure 1a ). In all, 5.3% of cells show faint nuclear staining for b-catenin.
We determined the localization of endogenous APC in confluent cultures, reflecting cells as they may be present in the colon, but also being a model for the differentiated cells present in the central mass of a tumour (Brabletz et al., 2001) . We observed no change in localization of APC between subconfluent and Figure 1 Localization of APC and b-catenin in subconfluent and confluent HCT116, HEK293 and C57MG cells using confocal immunofluorescence microscopy. In subconfluent cells APC is observed either predominantly in the cytoplasm or equally distributed between the cytoplasm and nucleus (b, f, j). In confluent cells a similar distribution of APC is observed (d, h, l) and we noted that cytoplasmic APC staining was often more pronounced than in subconfluent cells. In subconfluent cells b-catenin is predominantly located at the membrane with some cytoplasmic staining (a, e, i) with occasional HCT116 cells also showing nuclear staining (a). This same distribution is observed in confluent cells (c, g, k) with the exception that HCT116 cells show a reduction in the small number of cells with nuclear staining Location of truncated APC is a function of cell density in colon carcinoma epithelial cells
In subconfluent SW480 cells truncated APC is located predominantly in the nucleus with fainter cytoplasmic staining (Figure 2b ). Figure 3a records that 80.7% of cells display predominantly nuclear APC (in accordance with previous observations).
When SW480 cells are grown to high cell density truncated APC is not restricted to the nucleus of cells (Figure 2e ). There are largely three categories of staining observed; cytoplasm greater than nucleus, cytoplasm equal to nucleus and finally cytoplasm less than nucleus (the latter population being observed in subconfluent SW480 cells and the former populations being observed in HCT116 cells). The numbers of subconfluent and confluent SW480 cells that have APC distributed in each of the three categories are described in Figure 3 . That truncated APC is able to undergo nuclear export is in agreement with previous published data on subconfluent cells (Henderson, 2000; Neufeld et al., 2000) and would most likely utilize NES located at the N-terminus of APC. These data demonstrate that as SW480 cells progress to a higher cell density, truncated APC shows an altered localization pattern such that it is predominantly evenly spread between cytoplasm and nucleus (56.6%), a lesser population being cytoplasmic (28.3%), and the fewest cells demonstrating a nuclear localization (15.1%). Brocardo et al. (2001) reported that in the colon cancer cell line HT-29, APC responds to loss of cell-cell contacts by translocating from the cytoplasm to the nucleus. One implication of this is that b-catenin may be involved in regulating this relocalization following disruption of calcium-dependent binding. APC is located similarly, predominantly in the nucleus with fainter cytoplasmic staining (b, c). In confluent cells b-catenin shows two localizations, nuclear (with membrane and some cytoplasmic staining) and membrane only (with no nuclear staining) (d, f). Truncated APC in confluent cells is observed in three distribution categories, cytoplasm staining greater than nucleus, cytoplasm staining equal to nucleus and cytoplasm staining less than nucleus (e, f). In superconfluent cells the majority of cells have only membrane b-catenin with some cells having faint nuclear staining (g, i), in the majority of cells APC is either predominantly cytoplasmic or equally stained (h, i) Figure 3 The relationship between APC and b-catenin localization at low cell density is lost at high cell density in SW480 cells. In subconfluent cultures (a) the majority of cells show nuclear staining for both b-catenin and APC. In confluent cultures (b) two categories of b-catenin localization are observed: nuclear (with membrane staining) and membrane only. Three localizations are observed for APC: Nucleus more brightly stained than cytoplasm, nucleus and cytoplasm evenly stained and cytoplasm more brightly stained than nucleus. The colocalization between APC and bcatenin seen in subconfluent cultures is lost. These graphs show the mean of three repeats with error bars representing the range of the data Variable location and interactions of APC and b-catenin ML Davies et al
We therefore sought to define the relationship between APC and b-catenin at low and high cell density.
Truncated APC and b-catenin localization becomes uncoupled in cells grown to high cell density
In subconfluent SW480 cells both APC and b-catenin are similarly localized, predominantly in the nucleus with fainter cytoplasmic staining (Figure 2a-c) . bcatenin was also present (staining weakly) at the membrane of most cells. However, in confluent SW480 cells, b-catenin distribution is observed in two categories, either nuclear (and membrane) or membrane only (with no nuclear staining) and it does not colocalize with APC ( Figure  2d , f). The nuclear population of b-catenin in SW480 was noted to comprise of either a bright or faint level of staining, the reason for this is not clear and we grouped the two as a single nuclear population.
In superconfluent cells nuclear staining was only ever faint, notably, none of the previously recorded bright nuclear staining observed in subconfluent cells was present (data not shown). Figure 3 shows the interrelationship between APC and b-catenin localization in subconfluent versus confluent SW480 cells, with APC distribution being described within each of the two categories of b-catenin location. A tight coupling of localization between b-catenin and truncated APC is observed in subconfluent cells (Figure 3a) . However, in confluent SW480 cells this association is lost, with no apparent link in distribution pattern (Figure 3b) .
One possible explanation for the uncoupling of bcatenin and APC localization is that their colocalization is linked to proliferating cells. We looked at the correlation between cells labeled with Ki-67 at high cell density and the localization of b-catenin and APC in these cells. No correlation was observed between bcatenin and APC localization and Ki-67 expression (data not shown).
Extent of CRM1-dependent nuclear export of b-catenin alters from low to high cell density in colon-cancer epithelial cells CRM1-dependent nuclear export of b-catenin by APC has been shown by several groups (Henderson, 2000; Rosin-Arbesfeld et al., 2000 , 2003 . In addition, a CRM1-independent mechanism has also been shown in cells overexpressing b-catenin (Eleftheriou et al., 2001) and in cells where b-catenin is not efficiently regulated by degradation, for example, in wnt stimulated or APC mutant cancer cells (Henderson and Fagotto, 2002) . Although it has been proposed that CRM1-independent export of b-catenin is slow and that this rate is accelerated by APC (Rosin-Arbesfeld et al. Variable location and interactions of APC and b-catenin ML Davies et al mediate b-catenin distribution through a CRM1-dependent mechanism to a significant extent. b-catenin either remains largely bound to the membrane or exits the nucleus by a CRM1-independent mechanism, consistent with that described by Eleftheriou et al. (2001) and Henderson and Fagotto (2002) .
In confluent SW480 cells, 81.7% of cells show accumulation of nuclear b-catenin following LMB treatment (Figure 4a ). Untreated controls show nuclear b-catenin staining in only 47.9% of cells therefore a significant proportion of cells (33.8%) that do not show nuclear staining when untreated do demonstrate nuclear accumulation of b-catenin with LMB treatment. There is a decrease in the number of superconfluent cells showing nuclear accumulation of b-catenin compared to confluent cells, from 81.7 to 63.5% (Figure 4b ), but also a corresponding decrease in the percentage of untreated cells with nuclear b-catenin (19.3%). It is also notable that the nuclear staining of b-catenin in superconfluent cells is only faint and we never observed the bright nuclear staining seen in subconfluent and confluent cultures (Figure 2g and 4b) .
In summary, when cancer cells are treated with LMB from low to high cell density, there is a reduction in the percentage of cells that accumulate b-catenin in response to LMB. Two alternatives may explain this, firstly, bcatenin remains outside the nucleus and does not enter or secondly, b-catenin exits by a CRM1-independent mechanism at high cell density. Furthermore we also noted that at high cell density a higher proportion of cells with truncated APC accumulate nuclear b-catenin in response to LMB compared to cells with full-length APC and mutated b-catenin.
CRM1-dependent nuclear export of b-catenin does not occur in noncancer epithelial cell lines
We tested whether the response to LMB treatment by bcatenin prevailed in the noncancer epithelial cell lines HEK293, C57MG and MDCK cells. When these cells were treated with LMB at low and high cell density, there was no nuclear accumulation of b-catenin (Figure  4e-j) .
b-Catenin is bound to APC in higher levels at low cell density and to E-cadherin in higher levels at high cell density Brocardo et al. (2001) reported that APC translocates to the nucleus in response to the loss of cell to cell contacts. One explanation for this could be the loss of b-catenin from junctions, resulting in increased levels of nuclear bcatenin, causing APC to translocate to the nucleus to export b-catenin. In this report, we have shown that noncancer cells do not accumulate nuclear b-catenin in response to treatment by LMB. Accordingly, one explanation for this could be that membrane-associated b-catenin is bound to E-cadherin in junctions and is thereby unable to move into the nucleus, while the cytoplasmic pool is efficiently degraded. This may also explain why in cancer cells the response of b-catenin to treatment with LMB becomes less with increased cell density. Furthermore, we observe that in the cancer cell line SW480 there is an increase in the brightness of bcatenin staining at their membranes as cells are grown from low to high cell density. Following on from these data, we tested the hypothesis that increased involvement of b-catenin in complexes with E-cadherin at membrane junctions underlies the uncoupling of APC and b-catenin localization at high cell density in SW480 cells.
The total levels of E-cadherin, APC and b-catenin that are expressed in SW480 cells at low and high cell density were compared ( Figure 5 ). There is an increase in the expression levels of E-cadherin, a 2.3-fold decrease in the expression levels of APC, while the levels of b-catenin remain constant as cells are grown from low to high cell density (Figure5 and data not  shown) . Furthermore, immunofluorescence data shows an actual increase in the number of cells expressing membrane E-cadherin (data not shown) consistent with previous reports (Brabletz et al., 2001) . We then compared the extent of interactions through coimmunoprecipitations between b-catenin with E-cadherin and APC relative to the total expression levels in whole-cell lysate, as cells were grown from low to high cell density. There is an 18-fold increase in the levels of interaction observed between b-catenin and E-cadherin as cells are grown from low to high cell density ( Figure 5 ). There is a 10.7-fold decrease in the levels of interaction between b-catenin and APC as cells are grown from low to high cell density ( Figure 5 ). Levels of protein were normalized against b-catenin.
We next carried out immunofluorescence microscopy to determine whether E-cadherin and b-catenin colocalized at the membrane in cells grown to high cell density. Although many cells showed that b-catenin and Ecadherin were similarly located at the membrane, there were many cells that displayed membrane staining for only b-catenin and not E-cadherin (Figure 6 ). In summary, interactions between b-catenin and Ecadherin are increased while interactions between bcatenin and APC decrease as cells are grown from low to high cell density. However, b-catenin does not always colocalize with E-cadherin at the membrane of highdensity cells, indicating that the relocalization effects observed are not a direct result of b-catenin being recruited to complexes with E-cadherin at adherens junctions.
Discussion
One of the CRM1-dependent nuclear export functions of APC is to control the levels of b-catenin in the nucleus of cells, and as such the two have been shown to colocalize in the nucleus of SW480 cells (and other cell lines with truncated APC) (Henderson, 2000; Neufeld et al., 2000; Rosin-Arbesfeld et al., 2000 , 2003 . In addition, b-catenin has been shown to undergo APCindependent nuclear export (Eleftheriou et al., 2001; Wieschens and Fagotto, 2001; Henderson and Fagotto, 2002) , although it is not determined when one mechanism may prevail over the other. One proposition is that CRM1-independent nuclear export is relatively slow and that this rate is accelerated by APC (Rosin-Arbesfeld et al., 2003) . Either way, the ability of APC to regulate the shuttling of b-catenin not only affects the localization of this protein, but also its ability to function depending on cellular context. b-catenin localization has been shown to alter depending on cell density (Brabletz et al., 2001; Dietrich et al., 2002) , and likewise APC (Brocardo et al., 2001; Zhang et al., 2001) . We report a comparison of localization of b-catenin and APC as cells are grown from low to high cell density.
We show that in colon carcinoma epithelial cells and two other noncancer epithelial cell lines with full-length APC, the subcellular distribution of this protein is independent of cell density. These results contrast those reported by Zhang et al. (2001) and we propose that this may be due to inherent differences between cell lines, suggesting that all data must be interpreted in the context of the cell line from which it was derived. However, cell density-dependent redistribution of truncated APC is observed in the cell line SW480, which has truncated APC, with the result that the majority of truncated APC does not reside in the nucleus at high cell density. Furthermore in these cells, subcellular redistribution of truncated APC is associated with an uncoupling of the colocalization with b-catenin observed in subconfluent cultures. As SW480 cells progress from low to high cell density there is a decrease in nuclear b-catenin staining and increased membrane staining. Superconfluent SW480 more closely resemble HCT116, HEK293 and C57MG cells in their final distribution of APC and b-catenin implying that the mutation in APC is only having a significant effect on APC and b-catenin localization at low cell density.
We also found that the response of cancer cell lines to LMB treatment changes with cell density. Both SW480 and HCT116 cells accumulate less nuclear b-catenin (in response to LMB) at high cell density, with b-catenin being predominantly seen at the membrane. In contrast in noncancer cell lines there is no accumulation of nuclear b-catenin in response to treatment with LMB, under any conditions tested. This implies that in the cancer cell lines at high cell density, and in the noncancer cell lines, either a CRM1-independent export mechanism is used, or that b-catenin is anchored at the membrane and does not shuttle.
As mentioned, we noted an increased amount of bcatenin at the cell membranes at high cell density. Also Brocardo et al. (2001) noted that APC translocates to the nucleus when cell to cell contacts are disrupted. We therefore reasoned that the uncoupling of b-catenin from APC in SW480 cells at high cell density may be regulated by the alternate binding of b-catenin to Ecadherin at adherens junctions. It has been shown previously that APC and cadherins form mutually exclusive and competitive complexes with b-catenin (Hulsken et al., 1994; Rubinfeld et al., 1995) . E-cadherin expression levels are somewhat altered in tumours and they are often downregulated during tumour progression (Behrens et al., 1989; Perl et al., 1998) . As SW480 cells are grown from low to high cell density we have shown that the total level of E-cadherin expressed is increased and that the total level of APC expressed is decreased. There is an increase in the total levels of interactions detected between b-catenin and Ecadherin and a decrease in the levels of interaction detected between b-catenin and APC. This could be due to alterations in the strength of interactions between two proteins under particular conditions, or changes in the amount of protein available for interaction. When bcatenin is bound to E-cadherin it is unable to transactivate TCF/LEF targets (Sadot et al., 1998; Orsulic et al., 1999) and E-cadherin mediates its growth suppressor activity through inhibiting TCF/LEF: bcatenin interactions (Gottardi et al., 2001) . Therefore any increase in binding between b-catenin and Ecadherin at high cell density may lead to a decrease in transactivation of target genes. Notably, in HEK293 cells we found an increase in the levels of E-cadherin protein expressed from low to high cell density with a similar increase in the levels of interaction between bcatenin and E-cadherin (data not shown). However, in these cells the increase in binding between b-catenin and Variable location and interactions of APC and b-catenin ML Davies et al E-cadherin was only threefold compared to 18-fold in SW480 cells. The elevated increase in binding between bcatenin and E-cadherin observed in SW480 cells (compared to HEK293 cells) could be due to two reasons. Firstly, the abnormally low levels of E-cadherin expressed in subconfluent SW480 cells may make the increase in binding relatively higher. Secondly, because b-catenin is mainly nuclear (only weak staining at the membrane) in subconfluent SW480 cells, it is unable to bind to E-cadherin. If more b-catenin is bound to Ecadherin, then how does this relate to cell density redistribution of b-catenin and APC in SW480 cells?
A model proposed by Brabletz et al. (2001) suggests that colon carcinoma cells grown to low cell density represent the dedifferentiated mesenchymal-like cells similar to those found at the invasive front of tumours, expressing perinuclear E-cadherin. Our data suggests these cells would have b-catenin bound to APC, rather than E-cadherin, where APC has a nuclear export function and b-catenin is still able to transactivate TCF/ LEF-mediated transcription (Rosin-Arbesfeld et al., 2003) .
As cells are grown to higher density this same model proposes redifferentiation to cells with an epithelial phenotype, similar to cells found in the central mass of tumours that express membrane bound E-cadherin. Correspondingly, the increased binding of b-catenin to E-cadherin that we observe at high cell density may reflect a more differentiated state that is growth suppressed. This change in cell status is coincident with a proposed switch in APC function from the control of nuclear b-catenin degradation to maintenance of an epithelial redifferentiated phenotype. The latter would then involve b-catenin at the membrane bound cell junctions. A tight membrane association of b-catenin may depend on the presence of full-length APC stabilizing the junction through association with actin or microtubules at this site (Allan and Nathke, 2001; Rosin-Arbesfeld et al., 2001) . In SW480 b-catenin may be bound to E-cadherin at the membrane but the junctions may be relatively destabilized such that the membrane population is in equilibrium with the cytoplasmic population, thereby being available to shuttle between the nucleus and cytoplasm. The 'looser' membrane association could be a result of the truncation in APC affecting the binding of APC to actin and microtubules.
However since not all cells express both membrane bcatenin and E-cadherin (some express cytoplasmic APC, membrane b-catenin but not membrane E-cadherin) we consider it unlikely that formation of junctions is a single determining factor of density-dependent relocalization of APC and b-catenin in SW480 cells.
Materials and methods
Cell lines
Cell lines were maintained at 371C with 5% CO 2 SW480 (ECACC) and C57MG (kind gift from Anthony Brown) cells were grown in DMEM/10% FBS, HCT116 (ECACC) cells were grown in McCoy's 5a medium/10% FBS, HEK293 (ECACC) and MDCK (ECACC) cells were grown in MEM/ 10% FBS.
Immunofluorescence
Cells were seeded (5 Â 10 5 cells/dish for SW480, HCT116 and C57MG, 1 Â 10 6 cells/dish for HEK293, 5 Â 10 4 cells/dish for MDCK) in 40 mm tissue culture dishes. Cells were fixed and stained after being allowed to grow for 24 h (subconfluent), 3 days (confluent) or 5 days (superconfluent). Cells were washed in PBS, fixed with 4% paraformaldehyde for 20 min at room temperature, washed in PBS before being permeabilized in 0.2% Triton X-100 for 15 min at room temperature. After a further PBS wash cells were blocked in PBS-5%FBS for 1 h at room temperature. Cells were then incubated with primary antibodies diluted in PBS-5%FBS for 30-60 min at 371C, rinsed in PBS three times before incubation for 30-60 min at 371C in secondary antibodies diluted in PBS-5%FBS. Following secondary antibody incubation cells were again washed three times in PBS and stored in PBS until they were imaged using a Zeiss Axioplan 2 confocal microscope. Antibodies and dilutions used are as follows: M-APC 1 : 500 (kind gift from IS Nathke, University of Dundee), b-catenin H-102 1 : 75 (Santa-Cruz Biotechnology), b-catenin E-5 1 : 75 (Santa-Cruz Biotechnology), Ki-67 1 : 500 (Sigma), AlexaFluor 488 goat anti-mouse 1 : 400 (molecular Probes), AlexaFluor 568 goat anti-rabbit 1 : 400 (Molecular Probes).
LMB treatment
Cells were treated with LMB at a concentration of 10ng/ml for 4 h. Untreated controls were grown alongside LMB-treated cells. Immunofluorescence was carried out on LMB-treated cells as described above.
Immunoprecipitation and Western blot
Cells for immunoprecipitation (IP) and Western blot were collected by scraping, resuspended in lysis buffer (50 mM TrisHCl, pH7.4, 200 mM KAc, 0.5% Triton X-100, 1 mM AEBSF, 10 mM E-64, 2 mg/ml aprotinin, 1 mM pepstatin, 10 mM bestatin, 100 mM leupeptin, 1 mM sodium ortho-vanadate) and lysed in a FastPrep FP120. Lysates were then centrifuged at 20 000 g at 41C for 20 min. For Western blot Laemmli buffer was immediately added to lysates. For IP supernatants were incubated with 20 mg/ml b-catenin (E-5) antibody (Santa-Cruz) or normal IgG at 41C for 2-3 h. Protein G agarose beads were preblocked for 1 h in 4% milk and incubated with lysates for 1 h then washed three times in lysis buffer and resuspended in Laemmli buffer. Following boiling for 5 min lysates and IPs were run on 7.5% SDS-PAGE gels and transferred to PVDF membrane in Towbin buffer with 0.02% SDS at 600 mA for 15 h. Blots were probed with antibodies as follows: b-catenin (E-5) 1 : 1000 (Santa-Cruz); E-cadherin 1 : 2500 (Pharmingen); APC (ALI 12-28) 1 : 2500 (Upstate Biotech.). Densitometry measurements were carried out using Quantity One (BioRad).
